Abstract:Objective: The objective of this study was to evaluate and compare the pharmacokinetics of domperidone tablets in Chinese healthy subjects both under fasting and fed conditions. Materials and methods: A total of 36 subjects were recruited to the monocentric pharmacokinetic study. All subjects were randomly divided into two groups. One group was given a single 10-mg oral dose of domperidone tablet after similar to 10 hours of fasting, and the other group was given the same oral dose of domperidone tablet 30 minutes after a high-fat meal. 18 blood samples were collected over 24 hours for every subject. Plasma concentrations of domperidone were analyzed by a rapid and sensitive UPLC-MS/MS assay, and the pharmacokinetic parameters were determined by the standard non-compartmental method. Results: A significant difference was observed in the pharmacokinetics of domperidone between fasting and fed subjects. The AUC(0-24h) (area under curve of plasma concentration until the last concentration observed) was 75.71 hx mu g/L in the fed subjects, which was much higher than AUC(0-24h) (56.76 hx mu g/L) in the fasting subjects. For the fasting test. the T-1/2 (elimination half-life) was 7.15 hours, C-max (the maximum plasma concentration) was 16.97 mu g/L, and t(max) was 0.79 hours. For the fed test, the T-1/2 was 8.72 hours, C-max was 15.11 mu g/L, and t(max) was 1.66 hours. T-1/2 and t(max) were both prolonged under fed condition when comparing fed condition to fasting condition. Conclusion: In this study, the absorption and elimination of domperidone was slowed down by a high-fat meal, with the mean t(max) being 52% longer and T-1/2 18% longer in fed subjects than in fasting subjects. In addition, a high-fat meal increased the exposure of domperidone, with the mean AUC being 25% more in fed subjects than in fasting subjects, which provided an important reference for the clinical application of domperidone in the Chinese population.

Pharmacokinetics and bioequivalence study of domperidone tablets in human plasma

Determination of Domperidone in Human Plasma by HPLC-fluorescence and Evaluation on Its Bioequivalent

Bioequivalence of Domperidone Tablets in Healthy Male Volunteers

Bioequivalence of domperidone tablets in Chinese healthy volunteers after a single oral administration

Pharmacokinetics and Bioequivalence of Domperidone Chewable Tablets in Healthy Volunteers

Pharmacokinetics of Domperidone Tablets in Chinese Healthy Volunteers

Pharmacokinetics and relative bioavailability of domestic vs imported cefpodoxime proxetil tablets in human body

Determination of Domperidone in Human Plasma by LC-MS and Its Pharmacokinetics in Healthy Chinese Volunteers.

Development of a sensitive UPLC-MS/MS assay for domperidone and pharmacokinetics of domperidone tablet formulations in fasting and fed Chinese healthy subjects

Quantitative Determination of Domperidone in Human Plasma by Ultraperformance Liquid Chromatography with Electrospray Ionization Tandem Mass Spectrometry

Systematic Review of Domperidone in Clinical Practice

Bioequivalence Study of Ornidazole Tablet in Healthy Volunteers

Liquid Chromatography-Electrospray Quadrupole Linear Ion Trap Mass Spectrometric Method for Quantitation of Domperidone in Chinese Healthy Volunteers

Determination the Concentration of Domperidone in Human Plasma by LC - MS/MS

Bioavailability and Bioequivalence of Ondansetron Orally Disintegrating Tablets and Conventional Tablets

A Novel Domperidone Hydrogel: Preparation, Characterization, Pharmacokinetic, and Pharmacodynamic Properties

Study on the Bioequivalence of Rabeprazole Enteric- Coated Tablets in Human Plasma

Simultaneous determination of domperidone and Itopride in pharmaceuticals and human plasma using RP-HPLC/UV detection: Method development, validation and application of the method in in-vivo evaluation of fast dispersible tablets

Study on Bioequivalence of Dioxopromethazine Hydrochloride Granules in Healthy Volunteers

Bioequivalence of Risperidone Orally Disintegrating Tablets in Healthy Volunteers

Bioequivalence of Pantoprazole Sodium Enteric-Coated Capsules in Human